277 related articles for article (PubMed ID: 15004877)
61. Effect of bladder distention on bladder base dose in gynaecological intracavitary high dose rate brachytherapy.
Adli M; Garipagaoglu M; Kocak Z
Br J Radiol; 2009 Mar; 82(975):243-8. PubMed ID: 19064593
[TBL] [Abstract][Full Text] [Related]
62. Optimized dose distribution of Gammamed plus vaginal cylinders.
Supe SS; Bijina TK; Varatharaj C; Shwetha B; Arunkumar T; Sathiyan S; Ganesh KM; Ravikumar M
Med Dosim; 2009; 34(1):20-5. PubMed ID: 19181251
[TBL] [Abstract][Full Text] [Related]
63. A dosimetric analysis of Morris, Fletcher, and Henschke systems for treatment of uterine cervix carcinoma.
Nath R; Urdaneta N; Bolanis N; Peschel R
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):995-1003. PubMed ID: 1917630
[TBL] [Abstract][Full Text] [Related]
64. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
[TBL] [Abstract][Full Text] [Related]
65. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
66. Patient-related factors determining geometry of intracavitary applicators and pelvic dose distribution during cervical cancer brachytherapy.
Senkus-Konefka E; Kobierska A; Jassem J; Badzio A
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):531-6. PubMed ID: 9112449
[TBL] [Abstract][Full Text] [Related]
67. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
Pötter R; Van Limbergen E; Gerstner N; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
[TBL] [Abstract][Full Text] [Related]
68. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system.
Pham HT; Chen Y; Rouby E; Lustig RA; Wallner PE
Radiology; 1998 Feb; 206(2):525-31. PubMed ID: 9457208
[TBL] [Abstract][Full Text] [Related]
69. Changes in applicator positions and dose distribution between high dose rate brachytherapy fractions in cervix carcinoma patients receiving definitive radiotherapy.
Garipağaoğlu M; Tunçel N; Dalmaz MG; Gülkesen H; Toy A; Kizildağ AU; Köseoğlu FG
Br J Radiol; 2006 Jun; 79(942):504-9. PubMed ID: 16714753
[TBL] [Abstract][Full Text] [Related]
70. Rectal doses in intracavitary brachytherapy of gynecological malignancies: comparison of two dosimetric methods.
Serkies K; Badzio A; Jereczek-Fossa B; Tarnawska Z; Nowak R; Szewczyk P; Jassem J
Radiother Oncol; 2001 Jan; 58(1):37-41. PubMed ID: 11165680
[TBL] [Abstract][Full Text] [Related]
71. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications.
Sakata K; Nagakura H; Oouchi A; Someya M; Nakata K; Shido M; Koito K; Sagae S; Kudo R; Hareyama M
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1369-76. PubMed ID: 12459359
[TBL] [Abstract][Full Text] [Related]
72. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study.
el-Baradie M; Inoue T; Inoue T; Murayama S; Tang JT; Yamazaki H; Fournier-Bidoz N
Strahlenther Onkol; 1997 Mar; 173(3):155-62. PubMed ID: 9122857
[TBL] [Abstract][Full Text] [Related]
73. In vivo diode dosimetry vs. computerized tomography and digitally reconstructed radiographs for critical organ dose calculation in high-dose-rate brachytherapy of cervical cancer.
Hassouna AH; Bahadur YA; Constantinescu C; El Sayed ME; Naseem H; Naga AF
Brachytherapy; 2011; 10(6):498-502. PubMed ID: 21640661
[TBL] [Abstract][Full Text] [Related]
74. A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
Mourya A; Choudhary S; Shahi UP; Sharma N; Gautam H; Patel G; Pradhan S; Aggarwal LM
Brachytherapy; 2021; 20(1):118-127. PubMed ID: 32811759
[TBL] [Abstract][Full Text] [Related]
75. Comparisons between the KKU-model and conventional rectal tubes as markers for checking rectal doses during intracavitary brachytherapy of cervical cancer.
Padoongcharoen P; Krusun S; Palusuk V; Pesee M; Supaadirek C; Thamronganantasakul K
Asian Pac J Cancer Prev; 2014; 15(15):6115-20. PubMed ID: 25124583
[TBL] [Abstract][Full Text] [Related]
76. Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial.
Mahantshetty U; Lewis S; Engineer R; Swamidas J; Chopra S; Gurram L; Kinhikar R; Deshpande D; Kirisits C; Shrivastava S
Brachytherapy; 2021; 20(6):1146-1155. PubMed ID: 34598883
[TBL] [Abstract][Full Text] [Related]
77. Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy.
Shukla AK; Rana BS; Singh NP; Kumar S
Brachytherapy; 2019; 18(2):180-185. PubMed ID: 30616914
[TBL] [Abstract][Full Text] [Related]
78. Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment.
Saini AS; Zhang GG; Finkelstein SE; Biagioli MC
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1263-7. PubMed ID: 20950949
[TBL] [Abstract][Full Text] [Related]
79. Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer.
Sud S; Roth T; Jones E
J Contemp Brachytherapy; 2018 Feb; 10(1):32-39. PubMed ID: 29619054
[TBL] [Abstract][Full Text] [Related]
80. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.
Datta NR; Srivastava A; Maria Das KJ; Gupta A; Rastogi N
Brachytherapy; 2006; 5(4):223-9. PubMed ID: 17118314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
